A Pharmaceutical Manufacturer Approached Quantzig to Help Them with Real-World Evidence Analytics and Design Better Treatment Options Print
Business Wire
Friday, 06 October 2017 03:06
Quantzig
Anirban Choudhury
Marketing Consultant
US: +1 630 538 7144
UK: +44 208 629 1455
hello@quantzig.com
https://www.quantzig.com/contact-us
Oct. 6, 2017 13:02 UTC

A Pharmaceutical Manufacturer Approached Quantzig to Help Them with Real-World Evidence Analytics and Design Better Treatment Options

LONDON--(BUSINESS WIRE)-- Quantzig, a global analytics solutions provider, has announced the completion of their latest real-world evidence analytics study on the pharmaceutical manufacturing industry. The client, a leading pharmaceutical manufacturer, wanted to track the market share and update reports based on changing stakeholder requirements. The client wanted to track future growth opportunities and augment their market shares.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171006005038/en/

Market Tracking and Real World Product Performance Analysis. (Graphic: Business Wire)

Market Tracking and Real World Product Performance Analysis. (Graphic: Business Wire)

According to the analytics experts at Quantzig, “Real-world evidence analytics helps pharmaceutical manufacturing companies to respond to the ever-changing market dynamics and compete with the major players to drive patient value.”

Globally, the pharmaceutical industry is rapidly transforming, and key players are identifying new approaches to uncover and better define the unmet needs of the customers. Organizations are adopting real-world evidence analytics to gain actionable insights into the treatment landscape. They are also gaining insights into the untapped opportunities and increasing market shares.

Request a free demo to see how Quantzig’s solutions can help you.

The solution offered by Quantzig helped the client to assess drug performance across numerous dimensions like market share, drug sales performance, and duration of therapy. The client was able to speed the development of new treatments and

provide better options to customers to stay ahead in the market.

This real-world evidence analytics solution provided benefits that helped the client to:

  • Track and

    Error. Page cannot be displayed. Please contact your service provider for more details. (25)

    monitor the market share and simulate outcomes for physicians
  • Design a rule-based algorithm to arrive at the best treatment option
  • To read more, request a free proposal

This real-world evidence analytics solution offered predictive insights on:

  • Identifying customers based on drug and
treatment usage
  • Understanding and analyzing the diverse patient data
  • To read more, request a free proposal
  • View the complete real-world evidence analytics study here:

    https://www.quantzig.com/content/real-world-evidence-pharmaceutical-firm

    About Quantzig

    Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 12 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on all of Quantzig’s services and the solutions they have provided to Fortune 500 clients across all industries, please contact us.

    Contacts

    Quantzig
    Anirban Choudhury
    Marketing Consultant
    US: +1 630 538 7144
    UK: +44 208 629 1455
    hello@quantzig.com
    https://www.quantzig.com/contact-us


    Source: Quantzig

    Smart Multimedia Gallery

    Market Tracking and Real World Product Performance Analysis. (Graphic: Business Wire)

    View this news release and multimedia online at:
    http://www.businesswire.com/news/home/20171006005038/en




    BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

    Add this page to your favorite Social Bookmarking websites
    Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
      BMR:1